Startup Showcase | LIC 2024

top of page

an opportunity within the Longevity Investors Conference for Start-Ups to present themselves in front of a selected audience of investors.

After a thorough review of numerous applications for the 2024 edition, we are presenting the exceptional ventures that are shaping the path to a healthier and extended lifespan.

We give the floor to these selected companies to give a 10-minute pitch presentation and have the chance to present their idea, values, and progress in front of investors interested in the Longevity, Rejuvenation, and wellness field.

THE SELECTED STARTUPS
2024 EDITION

Micregen has developed a platform technology to manipulate stem cells to produce multi-factorial 'off-the-shelf’, secretome products aimed at tackling degenerative deteriorating processes that are the main cause of many diseases.

Mogling Bio is developing novel pharmacological approaches to rejuvenate old stem cells.

Kyttaro Therapeutics is a development-stage platform technology company with a unique patent portfolio in clinical applications of genetically modified MSCs for treatment of diseases with a high, unmet clinical need.

Leucadia Therapeutics is determined to end Alzheimer's disease with Arethusta®, a first-in-class outpatient treatment.

metaShape Pharma is pioneering disease-targeting therapies for obesity, liver disease and chronic inflammation by transforming white fat on a cellular level.

Propion AKA How to Slow Time, Inc. aims to slow the aging process and enhance your health by targeting the relationship between the gut microbiome and the rest of the body.

Rasayana is harnessing the potential of Gut-Organ Axis biology to extend healthspan by developing novel, oral, safe, gut-targeted therapies addressing the fundamental hallmarks of aging.

Bottneuro pioneers precise, non-invasive brain stimulation using patient-specific MRI data to improve mental health and treat neurological disorders.

Cellcolabs specialises in industrial GMP production of high-quality Mesenchymal Stem Cells (MSC) in order to make them available at scale.

Cellergy is developing mitochondrial transplant therapy for in-vivo repeated administration.

If you wish to be a part of the Startup Showcase at next year's Longevity Investors Conference 2025, click the button below to apply.

START-UP SHOWCASE 2024

START-UP SHOWCASE
The package includes:

Opportunity to present during the conference - 10 minutes

Networking opportunities with selected 100+ investors

Accommodation for 3 nights

close to the event venue

Meals included

for 1 person - including the Opportunity to attend the Gala Dinner

Logo on the screens during the Start-Up Showcase panel

LI Final Color.png

© 2024 by Longevity Investors Ltd.

bottom of page